Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Boston University
Boston University
Washington University School of Medicine
Centre Oscar Lambret
Massachusetts General Hospital
Centre Jean Perrin
Institut Paoli-Calmettes
Abramson Cancer Center at Penn Medicine
University Health Network, Toronto
Istituti Clinici Scientifici Maugeri SpA
AdventHealth
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
University of Michigan Rogel Cancer Center
Centre Hospitalier Universitaire Dijon